XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning balance (shares) at Dec. 31, 2020   3,168,823    
Beginning Balance at Dec. 31, 2020 $ 184,080,753 $ 80,810,946 $ (14,748,118) $ 118,017,925
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   52,434    
Issuance of restricted stock grants   $ 8,160,714 (8,160,714)  
Amortization of restricted stock grants 1,397,132   1,397,132  
Issuance of stock grants (in shares)   3,681    
Issuance of stock grants 529,806 $ 529,806    
Issuance of common stock related to 401k plan match (in shares)   154    
Issuance of common stock related to 401k plan match 24,000 $ 24,000    
Shares withheld related to employee tax withholding (in shares)   (1,729)    
Shares withheld related to employee tax withholding (258,088) $ (258,088)    
Forfeiture of restricted stock grants (shares)   (13,200)    
Forfeiture of restricted stock grants   $ (2,070,780) 2,070,780  
Repurchase of common stock (shares)   (12,529)    
Repurchase of common stock (1,893,146) $ (1,893,146)    
Cash dividends paid (3,147,890)     (3,147,890)
Net income 13,708,511     13,708,511
Ending balance (shares) at Mar. 31, 2021   3,197,634    
Ending Balance at Mar. 31, 2021 194,441,078 $ 85,303,452 (19,440,920) 128,578,546
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2020 9,372,333      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (554,102)      
Net subscriptions of consolidated funds 738,711      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2021 $ 10,665,146      
Beginning balance (shares) at Dec. 31, 2021 3,171,536 3,171,536    
Beginning Balance at Dec. 31, 2021 $ 184,422,902 $ 80,434,049 (15,268,705) 119,257,558
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   66,190    
Issuance of restricted stock grants   $ 11,700,781 (11,700,781)  
Amortization of restricted stock grants 2,248,679   2,248,679  
Issuance of stock grants (in shares)   2,743    
Issuance of stock grants 487,870 $ 487,870    
Issuance of common stock related to 401k plan match (in shares)   108    
Issuance of common stock related to 401k plan match 19,249 $ 19,249    
Issuance of common stock related to employee stock purchase plan (in shares)   2,335    
Issuance of common stock related to employee stock purchase plan 437,346 $ 437,346    
Forfeiture of restricted stock grants (shares)   (1,321)    
Forfeiture of restricted stock grants   $ (244,509) 244,509  
Repurchase of common stock (shares)   (50,104)    
Repurchase of common stock (9,317,661) $ (9,317,661)    
Cash dividends paid (4,818,318)     (4,818,318)
Net income $ 9,129,952     9,129,952
Ending balance (shares) at Mar. 31, 2022 3,191,487 3,191,487    
Ending Balance at Mar. 31, 2022 $ 182,610,019 $ 83,517,125 $ (24,476,298) $ 123,569,192
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2021 17,756,336      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest 854,936      
Net subscriptions of consolidated funds 3,837,120      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2022 $ 20,738,520